Imaging of pediatric lymphomas

Sara J Abramson1, Anita P Price

  • 1Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. abramsos@mskcc.org

Insights

Pediatric Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) are reviewed, focusing on how advanced imaging like PET-CT aids diagnosis, staging, and follow-up for these childhood cancers.

Area of Science:

  • Pediatric oncology
  • Radiology
  • Medical imaging

Background:

  • Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) constitute 10-15% of pediatric malignancies.
  • Recent advancements in cross-sectional imaging, including positron emission tomography (PET) and PET-CT, have significantly improved diagnostic and management strategies for pediatric lymphoma patients.

Purpose of the Study:

  • To review the clinical features of pediatric Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
  • To focus on the spectrum of imaging findings relevant to the diagnosis, staging, and follow-up of these pediatric hematologic malignancies.

Main Methods:

  • Review of clinical features and imaging findings in pediatric lymphoma.
  • Discussion of imaging modalities including cross-sectional imaging, PET, and PET-CT.
  • Categorization of pediatric NHL subtypes and identification of the primary HL subtype.

Main Results:

  • Imaging plays a crucial role in the diagnosis, staging, and follow-up of pediatric HL and NHL.
  • Key pediatric NHL subtypes include Burkitt lymphoma, diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and lymphoblastic lymphoma.
  • Nodular sclerosis is the most significant subtype of pediatric Hodgkin lymphoma.

Conclusions:

  • Advanced imaging techniques are integral to the comprehensive management of pediatric lymphoma.
  • Understanding the diverse imaging manifestations of HL and NHL subtypes is essential for accurate diagnosis and effective treatment planning in pediatric oncology.